Markets:

Overview

News

Currencies

International

Treasuries

Kodiak Sciences Inc - Common Stock (NQ:KOD)

38.35 +15.60 (+68.57%)

Streaming Delayed Price Updated: 9:49 AM EDT, Mar 26, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Kodiak Sciences Inc - Common Stock

< Previous 1 2 3 4 5 Next >

These stocks that are showing activity before the opening bell on Thursday. ↗

Today 9:30 EDT

Via Chartmill

Investment Firm Doubles Down on Biotech Stock, Adds 386,000 Shares, According to Recent SEC Filing ↗

March 09, 2026

This clinical-stage biotech targets retinal diseases with late-stage drug candidates and a focused pipeline in ophthalmology.

Via The Motley Fool

Topics Regulatory Compliance

Investment Manager Loads Up on CELC Stock, Adds 135,000 Shares, According to Latest SEC Filing ↗

March 06, 2026

This clinical-stage biotech develops precision oncology therapies and diagnostics targeting unmet needs in breast and ovarian cancer.

Via The Motley Fool

Topics Regulatory Compliance

Investment Firm Builds Position in TERN Stock, According to Recent SEC Filing ↗

March 05, 2026

This clinical-stage biotech develops small-molecule therapies for liver and metabolic diseases, targeting unmet needs in NASH and obesity.

Via The Motley Fool

Topics Regulatory Compliance

Investment Firm Bets Big on TNGX Stock With $9.5 Million Purchase, According to Recent SEC Filing ↗

March 04, 2026

This clinical-stage biotech develops targeted cancer therapies, leveraging strategic partnerships and a differentiated oncology pipeline.

Via The Motley Fool

Topics Regulatory Compliance

Kodiak Sciences Stock Up 480% as One Fund Discloses $53 Million Buy ↗

February 23, 2026

Focused on retinal disease therapeutics, this clinical-stage biotech advances drug candidates for vision-threatening conditions.

Via The Motley Fool

Topics Regulatory Compliance

Inside a $58 Million Bet on Kodiak Amid $184 Million Offering and Phase 3 Readouts Ahead ↗

February 19, 2026

Focused on retinal disease therapies, Kodiak Sciences leads with clinical-stage candidates targeting major unmet needs in ophthalmology.

Via The Motley Fool

Topics Regulatory Compliance

These stocks are gapping in today's session ↗

December 17, 2025

There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Wednesday.

Via Chartmill

This Coinbase Analyst Turns Bullish; Here Are Top 4 Upgrades For Friday ↗

October 24, 2025

Via Benzinga

Gapping stocks in Monday's session ↗

October 20, 2025

Today's session on Monday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.

Via Chartmill

WW International, Replimune Group, Datavault AI, GRAIL And Other Big Stocks Moving Higher On Monday ↗

October 20, 2025

Via Benzinga

Topics Artificial Intelligence

10 Health Care Stocks Whale Activity In Today's Session ↗

October 06, 2025

Via Benzinga

Ameresco, Lithium Americas, Kodiak Sciences And Other Big Stocks Moving Higher On Thursday ↗

September 25, 2025

U.S. stocks were lower, with the Nasdaq Composite falling more than 100 points on Thursday.

Via Benzinga

Topics Stocks

Top stock movements in today's session. ↗

September 22, 2025

Stay up-to-date with the latest market trends one hour before the close of the markets on Monday. Explore the top gainers and losers during today's session in our detailed report.

Via Chartmill

12 Health Care Stocks Moving In Monday's Intraday Session ↗

September 22, 2025

Via Benzinga

PROS Holdings, MBX Biosciences, Metsera, Anywhere Real Estate And Other Big Stocks Moving Higher On Monday ↗

September 22, 2025

Via Benzinga

Jim Cramer: Kodiak Sciences Is A 'Pure Spec' Stock, Recommends Buying This Utilities Stock ↗

August 27, 2025

Kodiak Sciences posted a second-quarter loss of $1.03 per share, compared to market estimates of a loss of $1.02 per share.

Via Benzinga

Kimball Electronics Posts Better-Than-Expected Earnings, Joins Terawulf, Dlocal, Equinox Gold And Other Big Stocks Moving Higher On Thursday ↗

August 14, 2025

Via Benzinga

Kodiak Sciences Beats Q2 Loss Estimates ↗

August 13, 2025

Via The Motley Fool

Topics Intellectual Property

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

May 15, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

May 06, 2025

Via Benzinga

The market is filled with gapping stocks in Wednesday's session. ↗

April 23, 2025

The session on Wednesday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.

Via Chartmill

These stocks are moving in today's pre-market session ↗

April 01, 2025

Discover the top movers in Tuesday's pre-market session and stay informed about market dynamics.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

February 12, 2025

Via Benzinga

Polaris, General Motors And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

January 28, 2025

Via Benzinga

Crude Oil Surges 2%; Tesla Shares Plummet ↗

January 02, 2025

Via Benzinga

Why Rumble Shares Are Trading Higher By Around 43%; Here Are 20 Stocks Moving Premarket ↗

December 23, 2024

Shares of Rumble Inc.

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

December 09, 2024

Via Benzinga

Pactiv Evergreen, RealReal, Kodiak Sciences And Other Big Stocks Moving Higher On Monday ↗

December 09, 2024

Via Benzinga

Eye-Disease Focused Kodiak Sciences Is A Promising 'Turnaround Story For 2025': Analyst Upgrades Stock ↗

December 09, 2024

Jefferies upgrades Kodiak Sciences, citing undervaluation and growth potential as Phase 3 trials advance for tarcocimab in retinal diseases.

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.